Search research articles
Contact Us
Filters
Showing results (631-640 of 663) with videos related to
Page
of 67
Sort By:
European Journal of Heart Failure
|
June 26, 2020
Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registries
Wouter Ouwerkerk, Tiew-Hwa K Teng, Jasper Tromp, et al.
European Journal of Heart Failure
|
February 20, 2018
CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how?
Kenneth Dickstein, Camilla Normand, Angelo Auricchio, et al.
European Journal of Heart Failure
|
January 13, 2018
Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF
Joost C Beusekamp, Jasper Tromp, Haye H van der Wal, et al.
Heart (British Cardiac Society)
|
April 1, 2021
Telomere length is independently associated with all-cause mortality in chronic heart failure
Simon P R Romaine, Matthew Denniff, Veryan Codd, et al.
BMC Medicine
|
November 11, 2016
Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives
João Pedro Ferreira, Nicolas Girerd, Pierpaolo Pellicori, et al.
International Journal of Cardiology
|
January 8, 2018
Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure
Jozine M Ter Maaten, Adriaan A Voors, Kevin Damman, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
April 6, 2021
Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial
João Pedro Ferreira, Timothy Collier, Andrew L Clark, et al.
Lancet (London, England)
|
August 27, 2019
Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study
Bernadet T Santema, Wouter Ouwerkerk, Jasper Tromp, et al.
Heart (British Cardiac Society)
|
May 10, 2024
Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial
Yu-Ling Yu, Justyna Siwy, De-Wei An, et al.
European Journal of Heart Failure
|
April 1, 2010
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine
Mihai Gheorghiade, Ferenc Follath, Piotr Ponikowski, et al.
Page
of 67
Search research articles
Search
Showing results (631-640 of 663) with videos related to
Sort By:
Page
of 67
European Journal of Heart Failure
|
June 26, 2020
Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registries
Wouter Ouwerkerk, Tiew-Hwa K Teng, Jasper Tromp, et al.
European Journal of Heart Failure
|
February 20, 2018
CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how?
Kenneth Dickstein, Camilla Normand, Angelo Auricchio, et al.
European Journal of Heart Failure
|
January 13, 2018
Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF
Joost C Beusekamp, Jasper Tromp, Haye H van der Wal, et al.
Heart (British Cardiac Society)
|
April 1, 2021
Telomere length is independently associated with all-cause mortality in chronic heart failure
Simon P R Romaine, Matthew Denniff, Veryan Codd, et al.
BMC Medicine
|
November 11, 2016
Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives
João Pedro Ferreira, Nicolas Girerd, Pierpaolo Pellicori, et al.
International Journal of Cardiology
|
January 8, 2018
Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure
Jozine M Ter Maaten, Adriaan A Voors, Kevin Damman, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
April 6, 2021
Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial
João Pedro Ferreira, Timothy Collier, Andrew L Clark, et al.
Lancet (London, England)
|
August 27, 2019
Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study
Bernadet T Santema, Wouter Ouwerkerk, Jasper Tromp, et al.
Heart (British Cardiac Society)
|
May 10, 2024
Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial
Yu-Ling Yu, Justyna Siwy, De-Wei An, et al.
European Journal of Heart Failure
|
April 1, 2010
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine
Mihai Gheorghiade, Ferenc Follath, Piotr Ponikowski, et al.
Page
of 67